Evidence map›Paper›PMID 27789681›Full record

ReviewThe Journal of pharmacology and experimental therapeutics2017

Estrogen Signaling as a Therapeutic Target in Neurodevelopmental Disorders.

Amanda Crider, Anilkumar Pillai

Open access · bronzeAbstract readReview
In one paragraph

Review in The Journal of pharmacology and experimental therapeutics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed, 2 pooled it
4.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 2 syntheses or guidelines pooled it, 76 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Editorial: Steroid receptors in neuron and glia.Frontiers in endocrinology · 2024
    Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Amanda CriderDepartment of Psychiatry and Health Behavior, Medical College of Georgia, Augusta University, Augusta, Georgia.
Anilkumar PillaiDepartment of Psychiatry and Health Behavior, Medical College of Georgia, Augusta University, Augusta, Georgia apillai@augusta.edu.
Augusta University · US

Funding

Regulation of TrkB signaling by 5-HT: role of transglutaminase 2R01MH097060 · NIMH · AUGUSTA UNIVERSITY · PI PILLAI, ANILKUMAR · 2012 to 2016
$1.5M
NIMH NIH HHS R01 MH097060
6 · The paper itself

Abstract

Estrogens, the primary female sex hormones, were originally characterized through their important role in sexual maturation and reproduction. However, recent studies have shown that estrogens play critical roles in a number of brain functions, including cognition, learning and memory, neurodevelopment, and adult neuroplasticity. A number of studies from both clinical as well as preclinical research suggest a protective role of estrogen in neurodevelopmental disorders including autism spectrum disorder (ASD) and schizophrenia. Alterations in the levels of estrogen receptors have been found in subjects with ASD or schizophrenia, and adjunctive estrogen therapy has been shown to be effective in enhancing the treatment of schizophrenia. This review summarizes the findings on the role of estrogen in the pathophysiology of neurodevelopmental disorders with a focus on ASD and schizophrenia. We also discuss the potential of estrogen as a therapeutic target in the above disorders.

Indexed as

AnimalsBrainEstrogensHumansMolecular Targeted TherapyNeurodevelopmental DisordersSignal TransductionEstrogens

Identifiers

PMID27789681
PMCPMC5193073
OpenAlexW2544447024

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.